Tejnaksh Healthcare Ltd.

67.88 +1.49 ▲2.2%

01 June 2023, 04:01:00 PM
Volume: 4,611

Company Profile

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.tejnaksh.com
Market Cap 68.94 Cr.
Enterprise Value(EV) 71.69 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 1.66 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 40.97 Trailing Twelve Months Ending 2023-03
Industry PE 48.20 Trailing Twelve Months Ending 2023-03
Book Value / Share 21.43 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.17 Calculated using Price: 67.88
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.02 Cr. 10,156,800 Shares
FaceValue 10
About Tejnaksh Healthcare Ltd.
The company is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to its patients in modern facilities. Its operations are divided across four key vertical streams in healthcare delivery, namely - “Pediatric Urology”, “Adult Urology (Male, Female)”, “Andrology and Sexual Dysfunction” and “Nephrology, Dialysis and Renal Transplant”. It offers a gamut of more than 65 healthcare services under these streams. A base of over 65 employees and consultants supports its healthcare facility network. The company's healthcare facilities use advanced technology and its doctors, nurses and other healthcare professionals follow treatment protocols that match international standards. A majority of its healthcare facilities provide secondary, tertiary and quaternary healthcare services to patients. Some of its healthcare facilities provide super speciality quaternary healthcare to patients in key specialty areas such as Pediatric Urology and Adult Urology (Male, Female).

Tejnaksh Healthcare Ltd. Delivery

Delivered Qty
Traded Qty

Tejnaksh Healthcare Ltd. Performance

1 Day
+2.24%
1 Week
-3.96%
1 Month
-7.03%
3 Month
-23.70%
6 Month
-43.78%
1 Year
-55.82%
2 Year
+11.46%
5 Year
-17.22%
10 Year

Tejnaksh Healthcare Ltd. Fundamental Ratios

7 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 21.17 26.68 34.98 26.93 15.10 12.71 15.05
Return on Capital Employed (%) 34.00 29.35 32.66 27.59 17.78 14.20 17.20
Return on Assets (%) 19.32 16.96 17.97 14.93 9.10 8.36 10.38

Tejnaksh Healthcare Ltd. Balance Sheet

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 6 8 10 13 15 17 20 22
Non Curr. Liab. 0 7 6 6 7 5 7 7
Curr. Liab. 0 1 3 2 2 2 2 2
Minority Int. 0 0 0 0 0 1 1
Equity & Liab. 7 16 20 22 25 25 30 31
Non Curr. Assets 6 14 17 18 18 21 25 25
Curr. Assets 1 2 3 5 7 3 5 6
Misc. Exp. not W/O
Total Assets 7 16 20 22 25 25 30 31

Tejnaksh Healthcare Ltd. Profit and Loss

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 5 7 14 20 17 12 13 12
Other Income 0 0 0 2 0 0 0 0
Total Income 5 7 15 21 17 12 13 12
Total Expenditure -2 -4 -9 -16 -13 -8 -8 -8
PBIDT 2 3 6 6 4 4 5 4
Interest 0 -1 -1 -1 -1 0 -1
Depreciation 0 0 0 -1 -1 -1 -1 -1
Taxation -1 -1 -1 -1 -1 -1 -1 -1
Exceptional Items
PAT 1 2 3 3 2 2 3 2
Minority Interest 0 0 0 0 0 0
Share Associate 0
Other Related Items
Consolidated Net Profit 1 2 3 3 2 2 3 2
Adjusted EPS 1 2 3 3 2 2 3 2

Tejnaksh Healthcare Ltd. Cash Flow

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 4 2 4 3 1 1 9
Cash Fr. Inv. -3 -8 -3 -2 -1 2 -11
Cash Fr. Finan. 0 6 -1 -2 0 -3 2
Net Change 0 1 1 -1 0 0 0
Cash & Cash Eqvt 0 1 2 1 1 1 1

Tejnaksh Healthcare Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 73.84 73.84 73.84 73.83 73.83 73.83 73.83 73.83 73.83
Public 26.16 26.16 26.16 26.17 26.17 26.17 26.17 26.17 26.17
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Tejnaksh Healthcare Ltd. Announcements

Tue, 30 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of SEBI {Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8" February 2019; we are attaching herewith the Annual Secretarial Compliance Report of the Company for the year ended 31° March 2023 issued by NS Dave and Associates Practicing Company Secretary and Secretarial Auditor of the Company.
Tue, 30 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance of provision of Regulation 47 read with Regulation 30 of the SEBI (LODR) Regulations 2015 the Company has published the Postal Ballot Notice.The Notice were published in Active Times (English Newspaper) and MumbaiLakshadweep (Marathi Newspaper) on May 26 2023.
Wed, 24 May 2023
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Submission of Postal Ballot Notice Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Tejnaksh Healthcare Ltd. Technical Scans

Thu, 01 Jun 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Below Last Week Low Close Below Last Week Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months

Tejnaksh Healthcare Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,934.33 987.50 +1.1%
Divi's Laboratories Ltd. 93,571.04 3,524.75 +2.1%
Cipla Ltd. 77,836.62 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. 75,790.17 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. 69,284.07 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. 60,079.14 1,775.15 -3.8%
Mankind Pharma Ltd. 56,008.27 1,398.15 +2.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.96 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 51.32 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 27.78 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.82 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 84.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.26 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 41.95 1,398.15 +2.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.23 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7.33 3,524.75 +2.1%
Cipla Ltd. Consolidated 2023-03 3.33 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.25 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.19 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 5.39 1,398.15 +2.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 0.04 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 13.10 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,398.15 +2.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,398.15 +2.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.50 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,524.75 +2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 964.25 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,551.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,819.00 +4.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,775.15 -3.8%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,398.15 +2.9%

Tejnaksh Healthcare Ltd. FAQ's

What is Tejnaksh Healthcare share price?

Can I buy Tejnaksh Healthcare shares now?

What is the Market Cap of Tejnaksh Healthcare?

What are the key metrics to analyse Tejnaksh Healthcare?

What is the 52 Week High and Low of Tejnaksh Healthcare?

What is the trend of Tejnaksh Healthcare share price?